ATAI Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances Catalyst Pharmaceuticals Inc CPRX Q1 2026 Earnings EPS Beats Estimates by 75 Stock Edges Slightly Lower AIRG Q1 2026 Earnings Mixed Results as Loss Slightly Exceeds Estimates GSAT Q1 2026 Earnings EPS Falls Short of Estimates Amidst Narrowing Revenue Visibility Genius Group Limited Q4 2022 Earnings Massive EPS Miss Erases Estimates as Stock Slides OPAD Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares